January 19, 2017
NeuroVive presents positive preclinical data in hepatocellular cancer at HCC Summit
NeuroVive Pharmaceutical’s abstract with novel preclinical cancer data related to the company’s sanglifehrin-based compounds has been accepted for presentation at…